Adimab (Lebanon, NH) a commercial-stage yeast-based antibody discovery and optimization platform, closed a $8.2M Series D financing. Participants include Google Ventures, OrbiMed, Borealis Ventures,Polaris Venture Partners and SV Life Sciences.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb